Detalles de la búsqueda
1.
Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment.
Support Care Cancer;
30(3): 2407-2415, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762217
2.
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
Int J Mol Sci;
22(20)2021 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681562
3.
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.
HPB (Oxford);
23(12): 1886-1896, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103247
4.
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction.
Eur J Cancer;
196: 113440, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37988843
5.
A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
Eur J Cancer;
181: 119-134, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652890
6.
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients.
Cancers (Basel);
15(17)2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686626
7.
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study.
J Oncol;
2022: 8549487, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35847365
8.
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.
Front Immunol;
13: 898498, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36091056
9.
Circulating Immunological Biomarkers: Prognosis of Pancreatic Cancer Patients Reflected by the Immune System.
Pancreas;
50(7): 933-941, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643608
10.
Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res;
27(23): 6602-6612, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580113
11.
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
Ther Adv Med Oncol;
13: 17588359211033704, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34422118
12.
Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer.
Clin Chim Acta;
505: 183-189, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145274
13.
RNA from stabilized whole blood enables more comprehensive immune gene expression profiling compared to RNA from peripheral blood mononuclear cells.
PLoS One;
15(6): e0235413, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32589655
14.
Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection.
Appl Sci (Basel);
9(22)2019 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34484811
15.
Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients.
Cancers (Basel);
11(1)2019 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650521
16.
The American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scale; translation and validation of the Dutch language version for ankle fractures.
BMJ Open;
7(8): e017040, 2017 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775193
Resultados
1 -
16
de 16
1
Próxima >
>>